Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

Anne Rodallec,1 Jean-Michel Brunel,2 Sarah Giacometti,1 Helene Maccario,3 Florian Correard,3 Eric Mas,3 Caroline Orneto,4 Ariel Savina,5 Fanny Bouquet,5 Bruno Lacarelle,1 Joseph Ciccolini,1 Raphaelle Fanciullino11SMARTc Unit, Pharmacokinetics Laboratory, CRCM UMR U1068 CNRS UMR 7258 Aix Marseille Un...

Full description

Bibliographic Details
Main Authors: Rodallec A, Brunel JM, Giacometti S, Maccario H, Correard F, Mas E, Orneto C, Savina A, Bouquet F, Lacarelle B, Ciccolini J, Fanciullino R
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:International Journal of Nanomedicine
Subjects:
immunoliposomes – biopharmaceutical development –breast cancer – docetaxel - trastuzumab - HER2
Online Access:https://www.dovepress.com/docetaxel-trastuzumab-stealth-immunoliposome-development-and-in-vitro--peer-reviewed-article-IJN

Internet

https://www.dovepress.com/docetaxel-trastuzumab-stealth-immunoliposome-development-and-in-vitro--peer-reviewed-article-IJN

Similar Items